Abstract 5775: GLIS3 drives a neural-like malignant state enriched after neoadjuvant treatment in pancreatic cancer
Jimmy A. Guo(Broad Institute), Andrew J. Aguirre(Broad Institute), Carina Shiau(Broad Institute), Connor J. Hennessey(Broad Institute), Julien Dilly(Massachusetts Institute of Technology), Brendan Parent(Unknown), David Ting(Massachusetts General Hospital), Brian M. Wolpin(Brigham and Women's Hospital), William L. Hwang(Massachusetts General Hospital), Laleh Abbassi(Broad Institute), Junning Wang(Dana-Farber Cancer Institute), Patrick Yu(University of Washington), Annan Yang(Dana-Farber Cancer Institute), Tyler Jacks(Howard Hughes Medical Institute), Qijia Yu(Dana-Farber Cancer Institute), Joseph D. Mancias(Brigham and Women's Hospital), Giselle Uribe(Dana-Farber Cancer Institute), Jennifer Su(Children's Hospital of Los Angeles), William A. Freed-Pastor(Broad Institute), Arnav Mehta(Broad Institute), Ananya Jambhale(New York University), Westley W. Wu(Broad Institute)
Cited by 2
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Mutant p53: one name, many proteins
|Genes & Development|2012|1.3k
Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
|Genes & Development|2003|1k